Used in pharmaceutical research as an intermediate in the synthesis of cysteine protease inhibitors. Shows potential in developing treatments for diseases involving abnormal protease activity, such as certain viral infections, inflammatory conditions, and cancer. Its structure supports targeted enzyme inhibition, enhancing selectivity and reducing off-target effects in drug design. Also investigated for use in prodrug formulations to improve metabolic stability and bioavailability.